European Event-Driven Analyst

Jesus Rodriguez Aguilar

Event-Driven

<ul>
<li>Pernod Ricard and Brown-Forman have ended merger talks, validating our view that governance and economics were irreconcilable; the control versus value transfer trade-off ultimately prevented agreement.</li>
<li>Brown-Forman weakens near-term as deal premium unwinds, but Sazerac’s ~$32 bid provides valuation support; execution risk remains high given leverage and loss of control for the Brown family.</li>
<li>The relative-value trade has played out; Brown-Forman shifts to takeover optionality, while Pernod Ricard reverts to fundamentals without an M&amp;A catalyst, with limited near-term upside.</li>
</ul>


Pernod Ricard and Brown-Forman have ended merger talks, validating our view that governance and economics were irreconcilable; the control versus value transfer trade-off ultimately prevented agreement.
Brown-Forman weakens near-term as deal premium unwinds, but Sazerac’s ~$32 bid provides valuation support; execution risk remains high given leverage and loss of control for the Brown family.
The relative-value trade has played out; Brown-Forman shifts to takeover optionality, while Pernod Ricard reverts to fundamentals without an M&amp;A catalyst, with limited near-term upside.


Pernod Ricard / Brown-Forman: Talks End – Control, Not Price, Was the Constraint

<ul>
<li>Pernod Ricard and Brown-Forman are exploring a merger at cyclical lows, with strategic rationale driven by distribution complementarities, but transaction economics hinge on governance asymmetry and allocation of c.$3bn synergies.</li>
<li>Brown-Forman’s controlling family (67.5% voting, ~25% economic interest) creates a high hurdle for any stock deal, likely requiring a 15–30% premium, implying dilution or leverage pressure for Pernod Ricard.</li>
<li>We favour long Brown-Forman versus short Pernod Ricard, hedged at ~0.39x, as most credible deal structures transfer value to Brown-Forman while exposing Pernod to dilution, governance concessions, and financing risk.</li>
</ul>


Pernod Ricard and Brown-Forman are exploring a merger at cyclical lows, with strategic rationale driven by distribution complementarities, but transaction economics hinge on governance asymmetry and allocation of c.$3bn synergies.
Brown-Forman’s controlling family (67.5% voting, ~25% economic interest) creates a high hurdle for any stock deal, likely requiring a 15–30% premium, implying dilution or leverage pressure for Pernod Ricard.
We favour long Brown-Forman versus short Pernod Ricard, hedged at ~0.39x, as most credible deal structures transfer value to Brown-Forman while exposing Pernod to dilution, governance concessions, and financing risk.


A Difficult Blend: Pernod Ricard / Brown-Forman and the Cost of Control

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

Brown Forman Corp Class B / Equity Bottom-Up

<ul><li>Brown-Forman has long stood as one of the clearest examples of a family-controlled alcohol empire that managed to preserve heritage, voting control, and brand prestige across generations.</li><li>That is why the reported merger talks with Pernod Ricard carry significance beyond ordinary deal speculation.</li><li>This is not merely a possible combination between Jack Daniel’s and a global spirits rival; it also reflects a broader shift in how legacy alcohol companies may need to operate in a slower-growth, more contested market.</li></ul>

Brown-Forman has long stood as one of the clearest examples of a family-controlled alcohol empire that managed to preserve heritage, voting control, and brand prestige across generations.That is why the reported merger talks with Pernod Ricard carry significance beyond ordinary deal speculation.This is not merely a possible combination between Jack Daniel’s and a global spirits rival; it also reflects a broader shift in how legacy alcohol companies may need to operate in a slower-growth, more contested market.

Brown Forman And Pernod Ricard: Is This The Deal That Ends Family Liquor Empires Forever?

<ul><li>Brown-Forman Corporation reported mixed results for the second quarter and first half of fiscal 2026, facing several challenges and opportunities.</li><li>The company experienced a 4% decline in reported net sales, while organic net sales remained flat when adjusted for the divestiture of Korbel and Sonoma-Cutrer from its portfolio.</li><li>A significant portion of this decline was due to macroeconomic and geopolitical uncertainties, particularly affecting consumer confidence and discretionary spending in the U.S. and developed international markets.</li></ul>

Brown-Forman Corporation reported mixed results for the second quarter and first half of fiscal 2026, facing several challenges and opportunities.The company experienced a 4% decline in reported net sales, while organic net sales remained flat when adjusted for the divestiture of Korbel and Sonoma-Cutrer from its portfolio.A significant portion of this decline was due to macroeconomic and geopolitical uncertainties, particularly affecting consumer confidence and discretionary spending in the U.S. and developed international markets.

Brown-Forman: From New Product Launches to Pricing Power—A Resilient Growth Story!

<ul><li>Brown-Forman Corporation reported mixed results for the first quarter of fiscal year 2026.</li><li>The company saw a modest increase in organic net sales by 1%, despite an overall decline of 3% in reported net sales due to acquisitions and divestitures (A&D) impacts and foreign exchange headwinds.</li><li>The performance was bolstered by strong growth in emerging international markets and travel retail, albeit offset by declines in developed international markets, particularly Germany and the UK, and a 2% decline in the United States.</li></ul>

Brown-Forman Corporation reported mixed results for the first quarter of fiscal year 2026.The company saw a modest increase in organic net sales by 1%, despite an overall decline of 3% in reported net sales due to acquisitions and divestitures (A&D) impacts and foreign exchange headwinds.The performance was bolstered by strong growth in emerging international markets and travel retail, albeit offset by declines in developed international markets, particularly Germany and the UK, and a 2% decline in the United States.

Brown-Forman Corporation: An Insight Into its Strategic Marketing

United States

Brown-Forman Corporation manufactures, bottles, imports, exports, and markets a wide variety of alcoholic beverage brands. The Company's products include branded whiskey, vodka, wines, tequila, bourbon, and gin.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Brown Forman Corp Class B (BF/B US)

Pernod Ricard / Brown-Forman: Talks End – Control, Not Price, Was the Constraint

Pernod–Brown talks end as governance trumps price. BF falls but $32 Sazerac bid sets a floor; PR loses M&A catalyst. Trade shifts from arb to BF...

Jesus Rodriguez Aguilar

A Difficult Blend: Pernod Ricard / Brown-Forman and the Cost of Control

Pernod–Brown talks are strategic but constrained by control. ~$3bn synergies exist, but Brown family leverage drives premium, leaving Pernod facing...

Jesus Rodriguez Aguilar

Brown Forman And Pernod Ricard: Is This The Deal That Ends Family Liquor Empires Forever?

Brown-Forman has long stood as one of the clearest examples of a family-controlled alcohol empire that managed to preserve heritage, voting...

Baptista Research

Brown-Forman: From New Product Launches to Pricing Power—A Resilient Growth Story!

Brown-Forman Corporation reported mixed results for the second quarter and first half of fiscal 2026, facing several challenges and...

Baptista Research

Brown-Forman Corporation: An Insight Into its Strategic Marketing

Brown-Forman Corporation reported mixed results for the first quarter of fiscal year 2026. The company saw a modest increase in organic net sales...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)